Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




“Virtual Slides” Reveal Disease Tissue in 3D

By LabMedica International staff writers
Posted on 07 May 2012
A fast, user-friendly system has been developed for examining tissue samples in “virtual” 3D images. More...
The novel digital scanning 3D reconstruction system produces high-resolution, multicolored images that can be rotated and examined from any angle.

Computing experts and medical researchers at the University of Leeds (Leeds, UK) have combined efforts to developed this technology as a particularly useful tool for histopathology researchers and potentially also for clinical practice, as medical imaging technology provides even higher resolution images of tissue.

Viewing tissue in 3D enables more in-depth understanding of tissue shape characteristics in ways not possible with conventional methods. Currently, hospital pathologists and medical researchers cut tissue samples into ultra-thin slices and routinely examine these by hand, one-by-one, on a microscope. This is a labor-intensive process - a single slide can contain several hundred thousand cells. To perform a 3D-like analysis, users would need to look at hundreds of different 2D sections - something that would be prohibitively expensive and time-consuming.

In contrast, the system developed at the University of Leeds requires almost no extra manual input once the tissue has been cut and mounted onto glass slides. An automated system turns batches of the slides into high-resolution digital images, which are then aligned using image registration software. Users, without input from computing specialists, can then study these virtual blocks of tissue in 3D and zoom in on particular areas of interest.

The researchers have now tested the system on eight different types of tissue, using more than 13,000 virtual slides to create around 400 separate 3D volumes. The system and selected case studies, including examples of liver disease, cancer, and embryology, are described in the May 2012 issue of the American Journal of Pathology.

This new approach to digital 3D reconstruction reveals more detailed information about disease processes - information that could be used to develop new therapies or explain why conventional treatments are not working. "Having a 3D view can often make a real difference," said Dr. Derek Magee, from the University of Leeds School of Computing, where the system’s software was developed. "For instance, if you want to understand how a system of blood vessels supplying a tumor connects up, you really need to see that in 3D, not as a series of separate 2D sections."

Related Links:

University of Leeds
Sample 3D images


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
HPV Test
Allplex HPV28 Detection
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.